There is a policy comment due out in Science today in which Genelex’s website is prejudicially quoted out of context. The quote in the article is: “Some Web sites make explicit claims about the utility of CYP450 testing for particular drugs, such as the claim by Genelex that pharmacogenetic testing is “required to effectively prescribe [...]
Filed under: Cytochrome P450, Drug Interactions, Personalized Medicine, Pharmacogenetics | Tagged: consumer driven healthcare, consumer right, CYP, DNA, P4 medicine, P450, Personalized Medicine, Pharmacogenetics, Science, testing | 4 Comments »
